List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 28 studies with search of: Open Studies | "Cytomegalovirus Infections"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine;   Drug: Placebo;   Biological: MF-59
2 Recruiting Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
Condition: Cytomegalovirus Infections
Interventions: Drug: Placebo;   Drug: Valganciclovir
3 Recruiting Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
Condition: Cytomegalovirus Infection
Intervention:
4 Recruiting Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
Condition: Cytomegalovirus Infections
Intervention: Drug: Artesunate
5 Recruiting Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
6 Recruiting Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
Condition: Cytomegalovirus Infection
Intervention: Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
7 Recruiting Genotyping of Cytomegalovirus From Patients in Israel
Condition: Cytomegalovirus Infections
Intervention:
8 Recruiting Dose-escalation Study of the Safety, Tolerability and Ability of CMX001 to Prevent or Control Cytomegalovirus (CMV) Infection in R+ Hematopoietic Stem Cell Transplant Recipients
Condition: Cytomegalovirus Infection
Interventions: Drug: CMX001;   Drug: Placebo
9 Recruiting Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Conditions: Heart Transplantation;   Cardiac Allograft Vasculopathy;   Cytomegalovirus Infection
Interventions: Drug: Pre-emptive strategy with valganciclovir plus everolimus;   Drug: Prophylaxis with valganciclovir plus mycophenolate;   Drug: Prophylaxis with valganciclovir plus everolimus;   Drug: Pre-emptive mycophenolate
10 Recruiting Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
Conditions: Stem Cell Transplantation;   Cytomegalovirus Infections
Intervention: Biological: CMV CTL infusion
11 Not yet recruiting Cytomegalovirus (CMV) Infection in Amniotic Fluid
Conditions: Pregnancy Complications;   Cytomegalovirus Infections
Intervention:
12 Recruiting CMV Glycoprotein B Vaccine in Allograft Recipients
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine;   Drug: Placebo
13 Recruiting Cytomegalovirus Cell-Mediated Immunity
Condition: Cytomegalovirus Infections
Intervention:
14 Recruiting Valganciclovir to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Cytomegalovirus Infections
Intervention: Drug: valganciclovir 900mg daily vs. placebo x 8 weeks
15 Recruiting In Utero Treatment of Cytomegalovirus Congenital Infection With Valacyclovir
Conditions: Viral Disease;   Cytomegalovirus Infection
Interventions: Drug: Valacyclovir (Zelitrex);   Drug: Placebo
16 Not yet recruiting Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
Condition: Cytomegalovirus Infection
Interventions: Drug: HCMV-specific hyperimmune globulin (Cytotect®);   Drug: Isotonic solution of sodium chloride (placebo)
17 Recruiting Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Conditions: Sensorineural Hearing Loss;   Cytomegalovirus Infection
Intervention:
18 Recruiting Safety, Toxicity and Maximum Tolerated Dose (MTD) of One Intravenous IV Injection of Donor Cytotoxic T-lymphocytes (CTLs) Specific for Cytomegalovirus (CMV) and Adenovirus
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: Dose Escalation Comparison
19 Recruiting Donor Lymphocytes in Preventing and Treating Cytomegalovirus Infection or Adenovirus Infection in Patients Who Have Undergone Umbilical Cord Blood Transplant
Condition: Cancer
Interventions: Biological: allogeneic CMV/AdV-specific cytotoxic T lymphocytes;   Other: laboratory biomarker analysis
20 Recruiting Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Condition: Cancer
Interventions: Biological: cytomegalovirus IE-1-specific cytotoxic T lymphocytes;   Biological: cytomegalovirus pp65-specific cytotoxic T lymphocytes;   Biological: therapeutic allogeneic lymphocytes;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunological diagnostic method;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-28)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services